A New Scoring System for Malignant Astrocytomas

Abstract

We are of the opinion that MAS represents a useful scoring system to determine the severity of the illness and make a prognosis for both individuals and groups of patients with malignant supratentorial astrocytoma. MAS is more accurate than predictions made by other systems currently in use; it includes prognostic factors that are widely accepted; it can be done at the patient's bedside and in clinics in developing societies.

The evaluation of malignant astrocytoma score (MAS)

“…Severity and prognosis of this illness depend on the ratio of the malignant potential of the tumor on one side, and immune defense against tumor cells on the other 1 suppressor genes and DNA repair genes) [2][3][4][5] . These factors are primal (direct) prognostic factors and because they are not well known and defined they are not used in the prognostic purpose routinely.…”